Ignitedata Secures Enterprise Agreement For Archer Platform, Streamlining EHR-To-EDC Data Transfer


(MENAFN- PR Newswire) WILMINGTON, Del., Oct. 17, 2024 /PRNewswire/ -- IgniteData, a company focused on healthcare technology solutions, announces a new collaboration with Mayo clinic to deploy its Archer platform across multiple sites in the U.S., aiming to improve the management of clinical trial data by enhancing the transfer of information from Electronic health Records (EHR) to Electronic Data Capture (EDC) systems.

Continue Reading

IgniteData works with research institutions globally, and this agreement, initially focused on oncology, seeks to increase Clinical Research Coordinator (CRC) efficiency and accelerate clinical trial processes. The automation and streamlining of data transfer through Archer reduces the need for manual data entry, providing quicker and more reliable data for drug development timelines.

IgniteData, announces a new collaboration with Mayo Clinic to deploy its Archer platform across multiple sites.

Post this

"This collaboration highlights our focus on improving clinical trial efficiency," said Tim Virdee, VP Hospital Partnerships at IgniteData. "By integrating the Archer platform, we aim to support faster and more reliable data transfer between EHR and EDC systems."

IgniteData's Archer platform was selected for its compatibility with multiple EHR and EDC systems and its commitment to data security, ensuring no patient data is persisted.

IgniteData
IgniteData is transforming the future of clinical trials through its cloud-based Virtual Research Assistant, Archer. A system-agnostic solution, Archer brings modern interoperability between EHR and key research systems, such as EDC, to provide seamless, secure transfer of clinically-validated data for clinical trials.

SOURCE IgniteData

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN17102024003732001241ID1108789750


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.